Sprout Health vs Direct Meds: verified GLP-1 prices
Sprout Health's checked prices are $149 every 4 weeks for compounded semaglutide and $199 every 4 weeks for compounded tirzepatide, rechecked 19 October 2026.
The same homepage does not publish a Wegovy or Zepbound price.
The $1,188 and $1,788 figures on that page are 12-month upfront totals for those compounded plans.
Sprout's compounded NAD+ is $249 a month after a first month at $199, checked 14 September 2026.
Direct Meds has no named-drug price in the ranked offers.
Its weight-loss page, checked 2 October 2026, lists a compounded GLP-1 injection from $297 a month and a compounded GLP-1 oral treatment from $249 a month.
That check describes the oral figure as a sublingual treatment and does not name the injection's drug.
We may earn a commission if you start a program through links on this page. It doesn't change prices or how we sort them. Disclosure
Sprout Health
- Ranked offers
- 5
- Lowest ranked offer
- $161.86/mo
Direct Meds
- Ranked offers
- 0
- Lowest ranked offer
- No ranked offer
Published prices on record
Each figure is the provider’s recorded price, with the page it was read from and the date it was checked. A starting price is not the same billing basis as a continuing monthly price.
Sprout Health
| Program | Price | Checked | Source |
|---|---|---|---|
| Compounded SemaglutideCompounded semaglutide injection | $149 every 4 weeks; $161.86 annualized monthly equivalent (365-day basis) | 21 October 2026 | Source |
| Compounded TirzepatideCompounded tirzepatide injection | $199 every 4 weeks; $216.18 annualized monthly equivalent (365-day basis) | 21 October 2026 | Source |
| Compounded NAD+Compounded NAD+ injection | $249 a month after a first month at $199 | 20 October 2026 | Source |
Programs both providers publish
No directly comparable programme format is currently recorded for both providers.
Sources and limits
Prices and terms can change. Confirm the current programme, eligibility, and total cost with the provider.
- Sprout Health homepage, 19 October 2026 Checked 19 October 2026. The rendered homepage prints compounded semaglutide at $149 every 4 weeks, or $99/mo on a 12-month plan paid as $1,188 upfront, and compounded tirzepatide at $199 every 4 weeks, or $149/mo on a 12-month plan paid as $1,788 upfront. It does not mention Wegovy or Zepbound. The $1,188 and $1,788 figures are those compounded prepaid totals.
- Direct Meds: attributed HIPAA and published-price statements Checked 2 October 2026. The provider states it follows HIPAA and publishes starting monthly figures of $297 for injections and $249 for sublingual treatment. This is a provider statement, not an independent compliance audit.
- Direct Meds weight-loss page: pricing (not yet coded as an offer) Checked 14 September 2026. "Plans start at $249/month for sublingual Semaglutide, and $297/month for injections." No comparison offer exists yet for this provider; flagged for onboarding-research.